VERACYTE INC's ticker is VCYT and the CUSIP is 92337F107. A total of 207 filers reported holding VERACYTE INC in Q1 2022. The put-call ratio across all filers is 1.25 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,291,861 | -34.4% | 102,636 | -25.1% | 0.00% | -25.0% |
| Q2 2023 | $3,492,420 | +120.9% | 137,119 | +105.8% | 0.00% | +100.0% |
| Q4 2022 | $1,581,343 | +229.4% | 66,639 | +130.7% | 0.00% | +100.0% |
| Q3 2022 | $480,000 | +91.2% | 28,891 | +129.1% | 0.00% | – |
| Q2 2022 | $251,000 | -74.0% | 12,610 | -64.0% | 0.00% | -100.0% |
| Q1 2022 | $965,000 | -32.4% | 34,987 | +1.0% | 0.00% | 0.0% |
| Q4 2021 | $1,427,000 | +8.8% | 34,628 | +5.5% | 0.00% | 0.0% |
| Q2 2021 | $1,312,000 | -61.2% | 32,826 | -47.8% | 0.00% | -75.0% |
| Q1 2021 | $3,379,000 | +61.1% | 62,866 | +46.7% | 0.00% | +33.3% |
| Q4 2020 | $2,097,000 | +267.9% | 42,854 | +144.4% | 0.00% | +200.0% |
| Q3 2020 | $570,000 | -62.7% | 17,536 | -70.3% | 0.00% | -66.7% |
| Q2 2020 | $1,529,000 | +1.9% | 59,016 | -4.3% | 0.00% | 0.0% |
| Q1 2020 | $1,500,000 | +302.1% | 61,696 | +362.3% | 0.00% | +200.0% |
| Q4 2019 | $373,000 | – | 13,346 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PERKINS CAPITAL MANAGEMENT INC | 119,680 | $2,672 | 2.65% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 239,571 | $5,349,620 | 1.62% |
| OBERWEIS ASSET MANAGEMENT INC/ | 597,540 | $13,343,068 | 1.42% |
| ARK Investment Management | 7,593,592 | $169,564,898 | 1.30% |
| Capital Impact Advisors, LLC | 32,969 | $736,198 | 1.23% |
| EFG Asset Management (North America) Corp. | 229,837 | $5,127,663 | 1.22% |
| Parkman Healthcare Partners LLC | 225,872 | $5,043,722 | 0.92% |
| Nikko Asset Management Americas, Inc. | 3,173,576 | $70,770,745 | 0.85% |
| Granite Investment Partners, LLC | 865,770 | $19,332,644 | 0.81% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 175,749 | $3,924,475 | 0.64% |